Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Completed 4Terminated 3Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Endometrial Neoplasms 3Anorexia 3Weight Loss 2Cachexia 2Body Weight 2Squamous Intraepithelial Lesions 1Recurrence 1Pancreatic Neoplasms 1Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1Body Weight Changes 1

Interventions

Megestrol Acetate 3anamorelin 1Watchful Waiting 1Observation 1Flurandrenolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Anorexia × Megestrol Acetate × Clear all
NCT00637728 2016-06-23

Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

Par Pharmaceutical, Inc.

Phase 3 Terminated
5 enrolled 8 charts
GastrointestinalThoracic

Anorexia, Body Weight, Cachexia, Lung Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

NCT01200602 2015-11-25

Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy

Mayo Clinic

Phase 2 Terminated
1 enrolled

Anorexia, Body Weight Changes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡